Monopar Therapeutics Inc. Shares Outstanding (Cover Page)
Monopar Therapeutics Inc. (MNPR) had Shares Outstanding (Cover Page) of 6.71 million shares as of 2026-07-31, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-07-31: Entity Common Stock, Shares Outstanding 6.71M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 6.70M shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 6.69M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 6.68M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 6.71M shares 10-Q · filed 2026-08-12 |
| 2026-04-30 | 6.70M shares 10-Q · filed 2026-05-14 |
| 2026-03-17 | 6.69M shares 10-K/A · filed 2026-04-01 |
| 2025-10-31 | 6.68M shares 10-Q · filed 2025-11-13 |
| 2025-07-31 | 6.17M shares 10-Q · filed 2025-08-12 |
| 2025-04-30 | 6.12M shares 10-Q · filed 2025-05-13 |
| 2025-03-14 | 6.11M shares 10-K · filed 2025-03-31 |
| 2024-10-31 | 5.28M shares 10-Q · filed 2024-11-08 |
| 2024-07-31 | 17.60M shares 10-Q · filed 2024-08-09 |
| 2024-04-30 | 17.48M shares 10-Q · filed 2024-05-09 |
| 2024-03-08 | 17.45M shares 10-K · filed 2024-03-28 |
| 2023-11-07 | 14.87M shares 10-Q · filed 2023-11-09 |
| 2023-07-28 | 14.16M shares 10-Q · filed 2023-08-10 |
| 2023-04-28 | 13.22M shares 10-Q · filed 2023-05-11 |
| 2023-03-10 | 13.19M shares 10-K · filed 2023-03-23 |
| 2022-10-31 | 12.86M shares 10-Q · filed 2022-11-10 |
| 2022-07-29 | 12.73M shares 10-Q · filed 2022-08-11 |
| 2022-04-30 | 12.62M shares 10-Q · filed 2022-05-12 |
| 2022-03-11 | 12.60M shares 10-K · filed 2022-03-24 |
| 2021-10-31 | 12.59M shares 10-Q · filed 2021-11-12 |
| 2021-07-31 | 12.58M shares 10-Q · filed 2021-08-12 |
| 2021-04-30 | 12.57M shares 10-Q · filed 2021-05-13 |
| 2021-03-05 | 12.57M shares 10-K · filed 2021-03-25 |
| 2020-10-31 | 11.45M shares 10-Q · filed 2020-11-12 |
| 2020-07-31 | 10.74M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 10.63M shares 10-Q · filed 2020-05-07 |
| 2020-03-13 | 10.62M shares 10-K · filed 2020-03-27 |
| 2019-11-12 | 9.29M shares 10-Q · filed 2019-11-12 |
| 2019-08-09 | 9.29M shares 10-Q · filed 2019-08-08 |
| 2019-05-10 | 9.29M shares 10-Q · filed 2019-05-10 |
| 2019-02-25 | 9.29M shares 10-K · filed 2019-02-26 |
| 2018-11-09 | 9.29M shares 10-Q · filed 2018-11-09 |
| 2018-08-09 | 9.29M shares 10-Q · filed 2018-08-09 |
| 2018-05-11 | 9.29M shares 10-Q · filed 2018-05-11 |
| 2018-03-26 | 9.29M shares 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |